Acne Vulgaris
Conditions
Brief summary
Evaluate the serum level of TWEAK in patients with AV and their relations before and after treatment with isotretinoin.
Detailed description
Acne vulgaris is a chronic inflammatory disease of the pilosebaceous follicles, characterized by comedones, papules, pustules, cysts, nodules, and occasionally scars. Its pathogenesis includes follicular hyperkeratinization, sebaceous hypersecretion due to androgen stimulation, follicular colonization by Propionibacterium acnes, immune and inflammatory responses. It affects the face, anterior chest, and upper back . Inflammation is regarded as a key component in the pathogenesis of acne . An increase in the activity of the pro inflammatory cytokine, interleukin (IL) 1, is observed before the beginning of hyperproliferation around the uninvolved follicles and is thought to trigger the activation of keratinocyte proliferation. Nuclear factor kappa beta (NF κβ) regulated mRNA gene levels of the cytokines tumour necrosis factor (TNF) α, IL 1 β, IL 8 and IL 10 levels also affected. Isotretinoin (13-cis retinoic acid) is a synthetic analog of vitamin A. Its oral form is prescribed for severe cases which are resistant to other treatments. Tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) belongs to the TNF superfamily. It has an important role in the regulation of cell growth, apoptosis, angiogenesis, and immune reactions.
Interventions
DRUGIsotretinoin
systemic isotretinoin was given to all 90 patients , dose was prescribed according to weight for 3 months
DIAGNOSTIC_TESTELISA Assays of Serum TWEAK.
: From each subject, 5mL of blood was collected into vacutainers before and after treatment with isotretinoin. The blood samples were centrifuged at 3000g for 10 min at a temperature of 4°C, then . Quantitative determinations for serum TWEAK were achieved using the corresponding commercially available ELISA kit supplied by the AssayMax
Sponsors
South Valley University
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
10 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
* Patients classified according to the global acne grading system(GAGS) into moderate, severe, and very severe cases
Exclusion criteria
* Pregnant and lactating women, patients with renal, GIT, skeletal, psychiatric, and endocrine disorders, sarcoidosis, and patients receiving drugs such as diuretics, multivitamins, anticonvulsants, glucocorticoids, erythromycin, estrogen compound pill were excluded.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| serum level of TWEAK | 12 weeks | To evaluate the serum level of TWEAK in patients with moderate to severe acne vulgaris. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| evaluate the effect of systemic isotretinoin on serum TWEAK level | 12 weeks | the comparison of the serum TWEAK before and after treatment with isotretinoin in moderate and severe cases of acne vulgaris. |
Countries
Egypt
Outcome results
None listed